Breaking News Instant updates and real-time market news.

BR

Broadridge

/

+

07:06
05/04/21
05/04
07:06
05/04/21
07:06

Broadridge raises FY21 adjusted EPS growth view to 11%-13% from 6%-10%

FY21 consensus $5.54. Raises FY21 revenue growth view to 8%-10% from 1%-4%, consensus $4.75B.

  • 04

    May

BR Broadridge
/

+

02/03/21 BTIG
Broadridge upgraded to Buy from Neutral at BTIG
12/18/20 Truist
Broadridge initiated with a Buy at Truist
12/18/20 Truist
Broadridge initiated with a Buy at Truist
08/17/20 JPMorgan
Broadridge price target raised to $152 from $142 at JPMorgan

TODAY'S FREE FLY STORIES

Recommendations
Wells says Coca-Cola Energy discontinuation may 'rekindle' Monster M&A debate » 13:46
05/14/21
05/14
13:46
05/14/21
13:46
MNST

Monster Beverage

$91.89 /

+2.475 (+2.77%)

, KO

Coca-Cola

$54.80 /

+0.29 (+0.53%)

Wells Fargo analyst Chris…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MNST Monster Beverage
$91.89 /

+2.475 (+2.77%)

KO Coca-Cola
$54.80 /

+0.29 (+0.53%)

MNST Monster Beverage
$91.89 /

+2.475 (+2.77%)

10:45 Today Evercore ISI
Coke Energy discontinuation a 'small positive' for Monster, says Evercore ISI
05/07/21 Truist
Monster Beverage price target raised to $115 from $105 at Truist
05/07/21 Deutsche Bank
Monster Beverage price target lowered to $105 from $109 at Deutsche Bank
04/29/21 Deutsche Bank
Monster Beverage price target raised to $109 from $105 at Deutsche Bank
KO Coca-Cola
$54.80 /

+0.29 (+0.53%)

10:45 Today Evercore ISI
Coke Energy discontinuation a 'small positive' for Monster, says Evercore ISI
04/20/21 Evercore ISI
Evercore raises Coca-Cola price target to $63, sees 'best' outlook 'in years'
04/20/21 Citi
Coca-Cola price target raised to $57 from $54 at Citi
04/12/21 Wolfe Research
Coca-Cola initiated with a Peer Perform at Wolfe Research
MNST Monster Beverage
$91.89 /

+2.475 (+2.77%)

KO Coca-Cola
$54.80 /

+0.29 (+0.53%)

MNST Monster Beverage
$91.89 /

+2.475 (+2.77%)

KO Coca-Cola
$54.80 /

+0.29 (+0.53%)

MNST Monster Beverage
$91.89 /

+2.475 (+2.77%)

KO Coca-Cola
$54.80 /

+0.29 (+0.53%)

MNST Monster Beverage
$91.89 /

+2.475 (+2.77%)

KO Coca-Cola
$54.80 /

+0.29 (+0.53%)

Recommendations
Ageas price target raised to EUR 57.20 from EUR 52.80 at Berenberg » 13:46
05/14/21
05/14
13:46
05/14/21
13:46
AGESY

Ageas

$62.92 /

-0.6495 (-1.02%)

Berenberg analyst Michael…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AGESY Ageas
$62.92 /

-0.6495 (-1.02%)

05/13/21 RBC Capital
Ageas price target raised to EUR 45 from EUR 40 at RBC Capital
03/16/21 Credit Suisse
Ageas price target raised to EUR 41 from EUR 33 at Credit Suisse
03/16/21 HSBC
Ageas downgraded to Hold from Buy at HSBC
03/16/21 HSBC
Ageas downgraded to Hold from Buy at HSBC
Recommendations
ABN Amro price target raised to EUR 9.30 from EUR 8.70 at Berenberg » 13:45
05/14/21
05/14
13:45
05/14/21
13:45
AAVMY

ABN Amro

$12.61 /

+0.28 (+2.27%)

Berenberg analyst Andrew…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AAVMY ABN Amro
$12.61 /

+0.28 (+2.27%)

05/13/21 Barclays
ABN Amro price target lowered to EUR 13 from EUR 13.50 at Barclays
05/13/21 JPMorgan
ABN Amro price target lowered to EUR 11.10 from EUR 11.30 at JPMorgan
05/13/21 RBC Capital
ABN Amro price target lowered to EUR 11 from EUR 11.50 at RBC Capital
05/13/21 UBS
ABN Amro price target lowered to EUR 10.50 from EUR 11 at UBS
Recommendations
Klepierre price target lowered to EUR 11.30 at Citi » 13:43
05/14/21
05/14
13:43
05/14/21
13:43
KLPEF

Klepierre

$27.68 /

-1.12 (-3.89%)

Citi analyst Aaron Guy…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KLPEF Klepierre
$27.68 /

-1.12 (-3.89%)

05/06/21 Societe Generale
Klepierre downgraded to Sell from Buy at Societe Generale
03/02/21 Berenberg
Klepierre price target raised to EUR 23 from EUR 18.50 at Berenberg
02/18/21 Deutsche Bank
Klepierre price target lowered to EUR 20 from EUR 21.50 at Deutsche Bank
01/22/21 Deutsche Bank
Klepierre price target lowered to EUR 21.50 from EUR 23 at Deutsche Bank
Recommendations
Alstom price target lowered to EUR 51 from EUR 52 at Credit Suisse » 13:41
05/14/21
05/14
13:41
05/14/21
13:41
ALSMY

Alstom

$5.17 /

-0.03 (-0.58%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALSMY Alstom
$5.17 /

-0.03 (-0.58%)

ALSMY Alstom
$5.17 /

-0.03 (-0.58%)

05/13/21 JPMorgan
Alstom price target lowered to EUR 49 from EUR 51 at JPMorgan
05/12/21 Deutsche Bank
Alstom price target lowered to EUR 51 from EUR 52 at Deutsche Bank
04/22/21 Deutsche Bank
Alstom upgraded to Buy from Hold at Deutsche Bank
03/17/21 JPMorgan
Alstom price target lowered to EUR 51 from EUR 52 at JPMorgan
ALSMY Alstom
$5.17 /

-0.03 (-0.58%)

Recommendations
Fraport price target raised to EUR 51 from EUR 44 at Credit Suisse » 13:40
05/14/21
05/14
13:40
05/14/21
13:40
FPRUY

Fraport

$34.65 /

-0.85 (-2.39%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FPRUY Fraport
$34.65 /

-0.85 (-2.39%)

05/12/21 Barclays
Fraport price target raised to EUR 44 from EUR 39 at Barclays
05/12/21 Deutsche Bank
Fraport price target raised to EUR 65 from EUR 58 at Deutsche Bank
04/13/21 JPMorgan
Fraport price target raised to EUR 54 from EUR 49 at JPMorgan
04/08/21 Berenberg
Fraport price target raised to EUR 59 from EUR 55 at Berenberg
Earnings
Qualigen Therapeutics reports Q1 EPS (13c), two estimates (16c) » 13:40
05/14/21
05/14
13:40
05/14/21
13:40
QLGN

Qualigen Therapeutics

$1.55 /

+0.025 (+1.64%)

Reports Q1 revenue $1.9M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
QLGN Qualigen Therapeutics
$1.55 /

+0.025 (+1.64%)

QLGN Qualigen Therapeutics
$1.55 /

+0.025 (+1.64%)

08/25/20 Alliance Global Partners
Qualigen upgraded to Buy from Neutral at Alliance Global Partners
QLGN Qualigen Therapeutics
$1.55 /

+0.025 (+1.64%)

Recommendations
AP Moller Maersk price target raised to DKK 18,451 at Credit Suisse » 13:40
05/14/21
05/14
13:40
05/14/21
13:40
AMKBY

AP Moller Maersk

$12.55 /

+0.035 (+0.28%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMKBY AP Moller Maersk
$12.55 /

+0.035 (+0.28%)

04:40 Today UBS
AP Moller Maersk downgraded to Neutral from Buy at UBS
05/13/21 AlphaValue
AP Moller Maersk upgraded to Add from Sell at AlphaValue
05/12/21 Goldman Sachs
AP Moller Maersk downgraded to Neutral from Buy at Goldman Sachs
05/12/21 Deutsche Bank
AP Moller Maersk downgraded to Hold from Buy at Deutsche Bank
AMKBY AP Moller Maersk
$12.55 /

+0.035 (+0.28%)

Recommendations
Vivendi price target lowered to EUR 32.20 from EUR 32.40 at Credit Suisse » 13:38
05/14/21
05/14
13:38
05/14/21
13:38
VIVHY

Vivendi

$34.85 /

+0.47 (+1.37%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VIVHY Vivendi
$34.85 /

+0.47 (+1.37%)

VIVHY Vivendi
$34.85 /

+0.47 (+1.37%)

04/23/21 Barclays
Vivendi price target raised to EUR 32 from EUR 31 at Barclays
04/23/21 Credit Suisse
Vivendi price target raised to EUR 32.40 from EUR 31.90 at Credit Suisse
04/13/21 Oddo BHF
Vivendi upgraded to Outperform from Neutral at Oddo BHF
03/08/21 Credit Suisse
Vivendi price target raised to EUR 31.90 from EUR 30.30 at Credit Suisse
VIVHY Vivendi
$34.85 /

+0.47 (+1.37%)

Recommendations
Zurich Insurance price target raised to CHF 445 from CHF 430 at Credit Suisse » 13:37
05/14/21
05/14
13:37
05/14/21
13:37
ZURVY

Zurich Insurance

$41.85 /

+0.42 (+1.01%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ZURVY Zurich Insurance
$41.85 /

+0.42 (+1.01%)

ZURVY Zurich Insurance
$41.85 /

+0.42 (+1.01%)

04/15/21 JPMorgan
Zurich Insurance price target raised to CHF 432 from CHF 430 at JPMorgan
03/30/21 Barclays
Zurich Insurance price target raised to CHF 415 from CHF 400 at Barclays
02/12/21 Oddo BHF
Zurich Insurance downgraded to Underperform from Neutral at Oddo BHF
02/09/21 UBS
Zurich Insurance price target raised to CHF 400 from CHF 390 at UBS
ZURVY Zurich Insurance
$41.85 /

+0.42 (+1.01%)

Recommendations
Beazley price target lowered to 350 GBp from 365 GBp at Credit Suisse » 13:37
05/14/21
05/14
13:37
05/14/21
13:37
BZLYF

Beazley

$4.10 /

-0.375 (-8.38%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BZLYF Beazley
$4.10 /

-0.375 (-8.38%)

BZLYF Beazley
$4.10 /

-0.375 (-8.38%)

04/26/21 BofA
Beazley initiated with a Buy at BofA
03/22/21 Investec
Beazley upgraded to Buy from Hold at Investec
02/08/21 JPMorgan
Beazley price target raised to 425 GBp from 405 GBp at JPMorgan
02/08/21 RBC Capital
Beazley price target raised to 480 GBp from 410 GBp at RBC Capital
Options
Western Digital call volume above normal and directionally bullish » 13:25
05/14/21
05/14
13:25
05/14/21
13:25
WDC

Western Digital

$71.15 /

+4.78 (+7.20%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WDC Western Digital
$71.15 /

+4.78 (+7.20%)

WDC Western Digital
$71.15 /

+4.78 (+7.20%)

04/30/21 Loop Capital
Western Digital price target raised to $90 from $65 at Loop Capital
04/30/21 Mizuho
Western Digital price target raised to $88 from $80 at Mizuho
04/30/21 Citi
Western Digital price target raised to $90 from $80 at Citi
04/26/21 Morgan Stanley
Morgan Stanley sees 'several ways' Western Digital stock 'can work'
WDC Western Digital
$71.15 /

+4.78 (+7.20%)

WDC Western Digital
$71.15 /

+4.78 (+7.20%)

WDC Western Digital
$71.15 /

+4.78 (+7.20%)

WDC Western Digital
$71.15 /

+4.78 (+7.20%)

General news
Oil Action: The weekly Baker Hughes oil rig count » 13:25
05/14/21
05/14
13:25
05/14/21
13:25
$ECON

Economic Data

/

+

Oil Action: The weekly…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
    Conference/Events
    Jefferies healthcare analysts to hold an analyst/industry conference call » 13:25
    05/14/21
    05/14
    13:25
    05/14/21
    13:25
    OLMA

    Olema Oncology

    $24.60 /

    +0.4 (+1.65%)

    , GILD

    Gilead

    $69.03 /

    +0.13 (+0.19%)

    , AZN

    AstraZeneca

    $55.25 /

    +0.2 (+0.36%)

    , SNY

    Sanofi

    $52.76 /

    +0.22 (+0.42%)

    Healthcare Analysts Yee…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    OLMA Olema Oncology
    $24.60 /

    +0.4 (+1.65%)

    GILD Gilead
    $69.03 /

    +0.13 (+0.19%)

    AZN AstraZeneca
    $55.25 /

    +0.2 (+0.36%)

    SNY Sanofi
    $52.76 /

    +0.22 (+0.42%)

    OLMA Olema Oncology
    $24.60 /

    +0.4 (+1.65%)

    12/14/20 JPMorgan
    Olema Oncology initiated with an Overweight at JPMorgan
    12/14/20 Jefferies
    Olema Pharmaceuticals initiated with a Buy at Jefferies
    12/14/20 Canaccord
    Olema Pharmaceuticals initiated with a Buy at Canaccord
    12/14/20 Cowen
    Olema Pharmaceuticals initiated with an Outperform at Cowen
    GILD Gilead
    $69.03 /

    +0.13 (+0.19%)

    04/01/21
    Fly Intel: Top five analyst upgrades
    04/01/21 Bernstein
    Gilead upgraded to Outperform from Market Perform at Bernstein
    03/30/21 Redburn
    Gilead upgraded to Buy from Neutral at Redburn
    03/15/21 Mizuho
    Merck's Gilead collaboration likely to broaden reach of islatravir, says Mizuho
    AZN AstraZeneca
    $55.25 /

    +0.2 (+0.36%)

    05/05/21 Oppenheimer
    Alexion upgraded to Outperform from Perform at Oppenheimer
    04/30/21 Wedbush
    Alexion's Q1 report 'uneventful' after FTC grants deal clearance, says Wedbush
    04/14/21 Guggenheim
    Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
    04/12/21
    Fly Intel: Top five analyst downgrades
    SNY Sanofi
    $52.76 /

    +0.22 (+0.42%)

    04/30/21 Deutsche Bank
    Sanofi price target raised to EUR 75 from EUR 70 at Deutsche Bank
    04/29/21 Barclays
    Sanofi price target raised to EUR 90 from EUR 85 at Barclays
    04/28/21 Stifel
    Protalix, Sanofi updates may signal headwinds for Avrobio, Amicus, says Stifel
    04/06/21 Barclays
    Sanofi price target raised to EUR 85 from EUR 80 at Barclays
    OLMA Olema Oncology
    $24.60 /

    +0.4 (+1.65%)

    GILD Gilead
    $69.03 /

    +0.13 (+0.19%)

    AZN AstraZeneca
    $55.25 /

    +0.2 (+0.36%)

    SNY Sanofi
    $52.76 /

    +0.22 (+0.42%)

    • 19
      Nov
    GILD Gilead
    $69.03 /

    +0.13 (+0.19%)

    AZN AstraZeneca
    $55.25 /

    +0.2 (+0.36%)

    SNY Sanofi
    $52.76 /

    +0.22 (+0.42%)

    OLMA Olema Oncology
    $24.60 /

    +0.4 (+1.65%)

    GILD Gilead
    $69.03 /

    +0.13 (+0.19%)

    AZN AstraZeneca
    $55.25 /

    +0.2 (+0.36%)

    SNY Sanofi
    $52.76 /

    +0.22 (+0.42%)

    OLMA Olema Oncology
    $24.60 /

    +0.4 (+1.65%)

    GILD Gilead
    $69.03 /

    +0.13 (+0.19%)

    AZN AstraZeneca
    $55.25 /

    +0.2 (+0.36%)

    Technical Analysis
    NASDAQ market internals summary » 13:17
    05/14/21
    05/14
    13:17
    05/14/21
    13:17
    $NSD

    NASDAQ Market Internals

    /

    +

    Volume is above average…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    $NSD NASDAQ Market Internals
    /

    +

    Hot Stocks
    Morningstar elects Fastly CPO Doniel Sutton to board of directors » 13:16
    05/14/21
    05/14
    13:16
    05/14/21
    13:16
    MORN

    Morningstar

    $247.47 /

    +2.37 (+0.97%)

    , FSLY

    Fastly

    $42.42 /

    +2.45 (+6.13%)

    Morningstar (MORN)…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    MORN Morningstar
    $247.47 /

    +2.37 (+0.97%)

    FSLY Fastly
    $42.42 /

    +2.45 (+6.13%)

    MORN Morningstar
    $247.47 /

    +2.37 (+0.97%)

    FSLY Fastly
    $42.42 /

    +2.45 (+6.13%)

    05/11/21 DA Davidson
    Fastly price target lowered to $60 from $105 at DA Davidson
    05/06/21 Craig-Hallum
    Fastly price target lowered to $55 from $80 at Craig-Hallum
    05/06/21 Oppenheimer
    Fastly price target lowered to $85 from $110 at Oppenheimer
    05/06/21 Piper Sandler
    Fastly price target lowered to $45 from $65 at Piper Sandler
    FSLY Fastly
    $42.42 /

    +2.45 (+6.13%)

    • 21
      May
    FSLY Fastly
    $42.42 /

    +2.45 (+6.13%)

    FSLY Fastly
    $42.42 /

    +2.45 (+6.13%)

    FSLY Fastly
    $42.42 /

    +2.45 (+6.13%)

    Technical Analysis
    NYSE market internals summary » 13:16
    05/14/21
    05/14
    13:16
    05/14/21
    13:16
    $NYE

    NYSE Market Internals

    /

    +

    Volume is above average…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    $NYE NYSE Market Internals
    /

    +

    Hot Stocks
    CDC says effectiveness study in health workers finds mRNA vaccines 94% effective » 13:15
    05/14/21
    05/14
    13:15
    05/14/21
    13:15
    PFE

    Pfizer

    $40.12 /

    +0.02 (+0.05%)

    , BNTX

    BioNTech

    $188.65 /

    +7.67 (+4.24%)

    , MRNA

    Moderna

    $157.99 /

    +8.22 (+5.49%)

    A new CDC study…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    PFE Pfizer
    $40.12 /

    +0.02 (+0.05%)

    BNTX BioNTech
    $188.65 /

    +7.67 (+4.24%)

    MRNA Moderna
    $157.99 /

    +8.22 (+5.49%)

    PFE Pfizer
    $40.12 /

    +0.02 (+0.05%)

    05/12/21 Canaccord
    BioNTech price target raised to $240 from $130 at Canaccord
    05/11/21 SVB Leerink
    BioNTech price target raised to $159 from $118 at SVB Leerink
    05/10/21 Morgan Stanley
    Pfizer price target raised to $42 from $38 at Morgan Stanley
    05/06/21
    Fly Intel: Top five analyst downgrades
    BNTX BioNTech
    $188.65 /

    +7.67 (+4.24%)

    05/12/21 Canaccord
    BioNTech price target raised to $240 from $130 at Canaccord
    05/11/21
    Fly Intel: Top five analyst downgrades
    05/11/21 SVB Leerink
    BioNTech price target raised to $159 from $118 at SVB Leerink
    05/11/21 Bryan Garnier
    BioNTech downgraded to Neutral from Buy at Bryan Garnier
    MRNA Moderna
    $157.99 /

    +8.22 (+5.49%)

    05/07/21 Barclays
    Moderna price target raised to $194 from $178 at Barclays
    05/07/21 Goldman Sachs
    Moderna price target raised to $228 from $206 at Goldman Sachs
    05/06/21 Piper Sandler
    Moderna price target lowered to $231 from $234 at Piper Sandler
    05/06/21 Needham
    Moderna execution 'continues to impress,' but reflected in stock, says Needham
    PFE Pfizer
    $40.12 /

    +0.02 (+0.05%)

    BNTX BioNTech
    $188.65 /

    +7.67 (+4.24%)

    MRNA Moderna
    $157.99 /

    +8.22 (+5.49%)

    • 23
      Jul
    • 19
      May
    PFE Pfizer
    $40.12 /

    +0.02 (+0.05%)

    BNTX BioNTech
    $188.65 /

    +7.67 (+4.24%)

    MRNA Moderna
    $157.99 /

    +8.22 (+5.49%)

    PFE Pfizer
    $40.12 /

    +0.02 (+0.05%)

    BNTX BioNTech
    $188.65 /

    +7.67 (+4.24%)

    MRNA Moderna
    $157.99 /

    +8.22 (+5.49%)

    PFE Pfizer
    $40.12 /

    +0.02 (+0.05%)

    BNTX BioNTech
    $188.65 /

    +7.67 (+4.24%)

    MRNA Moderna
    $157.99 /

    +8.22 (+5.49%)

    Syndicate
    Data Storage opened at $5.05, public offering priced at $6.75 » 13:15
    05/14/21
    05/14
    13:15
    05/14/21
    13:15
    DTST

    Data Storage

    $5.11 /

    -0.38 (-6.92%)

    Data Storage is a…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    • 14
      May
    Options
    Curis put volume heavy and directionally bearish » 13:15
    05/14/21
    05/14
    13:15
    05/14/21
    13:15
    CRIS

    Curis

    $13.68 /

    +0.64 (+4.91%)

    Bearish flow noted in…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    CRIS Curis
    $13.68 /

    +0.64 (+4.91%)

    CRIS Curis
    $13.68 /

    +0.64 (+4.91%)

    05/13/21 B. Riley
    Curis price target raised to $22 from $19 at B. Riley
    05/13/21 Cantor Fitzgerald
    Curis price target raised to $24 from $15 at Cantor Fitzgerald
    05/12/21 Cantor Fitzgerald
    Rigel rallying on Curis IRAK4 program data, says Cantor Fitzgerald
    05/12/21 Cantor Fitzgerald
    Initial look from Curis EHA updates 'very positive,' says Cantor Fitzgerald
    CRIS Curis
    $13.68 /

    +0.64 (+4.91%)

    • 09
      Dec
    CRIS Curis
    $13.68 /

    +0.64 (+4.91%)

    CRIS Curis
    $13.68 /

    +0.64 (+4.91%)

    Hot Stocks
    Baker Hughes reports U.S. rig count up 5 to 453 rigs » 13:07
    05/14/21
    05/14
    13:07
    05/14/21
    13:07
    BKR

    Baker Hughes

    $25.00 /

    +0.65 (+2.67%)

    Baker Hughes reports that…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    BKR Baker Hughes
    $25.00 /

    +0.65 (+2.67%)

    BKR Baker Hughes
    $25.00 /

    +0.65 (+2.67%)

    05/13/21 Goldman Sachs
    Baker Hughes initiated with a Buy at Goldman Sachs
    05/03/21 Barclays
    Baker Hughes upgraded to Overweight from Equal Weight at Barclays
    04/26/21
    Fly Intel: Top five analyst upgrades
    04/26/21 Citi
    Baker Hughes upgraded to Buy following underperformance at Citi
    BKR Baker Hughes
    $25.00 /

    +0.65 (+2.67%)

    BKR Baker Hughes
    $25.00 /

    +0.65 (+2.67%)

    BKR Baker Hughes
    $25.00 /

    +0.65 (+2.67%)

    BKR Baker Hughes
    $25.00 /

    +0.65 (+2.67%)

    Options
    PLBY Group call volume above normal and directionally bullish » 13:05
    05/14/21
    05/14
    13:05
    05/14/21
    13:05
    PLBY

    PLBY Group

    $45.79 /

    +5.415 (+13.41%)

    Bullish option flow…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    PLBY PLBY Group
    $45.79 /

    +5.415 (+13.41%)

    PLBY PLBY Group
    $45.79 /

    +5.415 (+13.41%)

    05/13/21 Craig-Hallum
    PLBY Group price target raised to $50 from $35 at Craig-Hallum
    05/13/21 Canaccord
    PLBY Group price target raised to $52 from $28 at Canaccord
    04/07/21 Roth Capital
    PLBY Group price target raised to $35 from $26 at Roth Capital
    04/06/21 Canaccord
    Canaccord sees Nifty Gateway partnership as initial step in PLBY's NFT strategy
    PLBY PLBY Group
    $45.79 /

    +5.415 (+13.41%)

    PLBY PLBY Group
    $45.79 /

    +5.415 (+13.41%)

    PLBY PLBY Group
    $45.79 /

    +5.415 (+13.41%)

    PLBY PLBY Group
    $45.79 /

    +5.415 (+13.41%)

    Recommendations
    Turquoise Hill price target lowered to C$24 from C$25 at Canaccord » 13:02
    05/14/21
    05/14
    13:02
    05/14/21
    13:02
    TRQ

    Turquoise Hill

    $16.36 /

    -0.47 (-2.79%)

    Canaccord analyst Dalton…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    TRQ Turquoise Hill
    $16.36 /

    -0.47 (-2.79%)

    TRQ Turquoise Hill
    $16.36 /

    -0.47 (-2.79%)

    12:51 Today BMO Capital
    Turquoise Hill price target lowered to C$18 from C$21 at BMO Capital
    11:44 Today Scotiabank
    Turquoise Hill price target lowered to C$30 from C$32 at Scotiabank
    05/13/21 Macquarie
    Turquoise Hill downgraded to Neutral from Outperform at Macquarie
    04/20/21 BMO Capital
    Turquoise Hill price target raised to C$20 from C$18 at BMO Capital
    TRQ Turquoise Hill
    $16.36 /

    -0.47 (-2.79%)

    Recommendations
    Xebec Adsorption price target lowered to C$4 from C$4.50 at Canaccord » 13:01
    05/14/21
    05/14
    13:01
    05/14/21
    13:01
    XEBEF

    Xebec Adsorption

    $3.10 /

    -0.08 (-2.52%)

    Canaccord analyst Yuri…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    XEBEF Xebec Adsorption
    $3.10 /

    -0.08 (-2.52%)

    XEBEF Xebec Adsorption
    $3.10 /

    -0.08 (-2.52%)

    12:07 Today Stifel
    Xebec Adsorption price target lowered to C$5 from C$5.60 at Stifel
    12:03 Today Raymond James
    Xebec Adsorption price target lowered to C$5.50 from C$6.50 at Raymond James
    11:49 Today National Bank
    Xebec Adsorption price target lowered to C$5 from C$6 at National Bank
    03/29/21 Desjardins
    Xebec Adsorption price target lowered to C$6.50 from C$7.50 at Desjardins
    XEBEF Xebec Adsorption
    $3.10 /

    -0.08 (-2.52%)

    Recommendations
    Slate Office REIT price target raised to C$5 from C$4.75 at Canaccord » 13:01
    05/14/21
    05/14
    13:01
    05/14/21
    13:01
    SLTTF

    Slate Office REIT

    $3.61 /

    + (+0.00%)

    Canaccord analyst Brendon…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    SLTTF Slate Office REIT
    $3.61 /

    + (+0.00%)

    11:51 Today National Bank
    Slate Office REIT price target raised to C$4.50 from C$4.25 at National Bank
    09:21 Today TD Securities
    Slate Office REIT downgraded to Hold from Buy at TD Securities
    01/22/21 National Bank
    Slate Office REIT price target raised to C$4.25 from C$4 at National Bank
    11/02/20 TD Securities
    Slate Office REIT price target lowered to C$5 from C$5.50 at TD Securities

    Get Full Fly Access

    Breaking market intelligence sent straight to you
    Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
    Up-to-date information on important industry events
    Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
    News focused on the companies in your portfolio
    Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.